DHG Pharmaceutical JSC (DHG) — Cash Flow-to-Debt Ratio
DHG Pharmaceutical JSC (DHG) has a Cash Flow-to-Debt Ratio of 0.46x as of December 2025, meaning its operating cash flow of ₫447.50 Billion could theoretically repay 0% of its total liabilities (₫983.26 Billion) in one year. See DHG Pharmaceutical JSC (DHG) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
DHG Pharmaceutical JSC Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for DHG Pharmaceutical JSC across 7 annual periods. Also explore DHG net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for DHG Pharmaceutical JSC (2019–2025)
Year-by-year debt coverage analysis for DHG Pharmaceutical JSC. For market capitalisation and broader financial context, see DHG market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (VND) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.24x | ₫1.22 Trillion | ₫983.26 Billion | ▲ +76.2% |
| 2024 | 0.71x | ₫1.32 Trillion | ₫1.86 Trillion | ▲ +217.5% |
| 2023 | 0.22x | ₫279.88 Billion | ₫1.26 Trillion | ▼ -78.4% |
| 2022 | 1.03x | ₫901.28 Billion | ₫876.65 Billion | ▲ +87.4% |
| 2021 | 0.55x | ₫452.44 Billion | ₫824.52 Billion | ▼ -41.6% |
| 2020 | 0.94x | ₫826.17 Billion | ₫879.46 Billion | ▼ -13.8% |
| 2019 | 1.09x | ₫838.24 Billion | ₫769.27 Billion | — |